By Karen Deyo, VP of Product, Israel BD, LSN
When pitching to investors, companies often focus on the science and the benefit to the patient. While of course important, they are missing crucial information investors need to make a decision on whether or not to move forward. Investors are busy – the quicker they can make a decision, the better – there is no guarantee they will have the time to look further into a company after a pitch, so companies should make the best use of their attention while they have it.
How do investors make their decisions? What questions do they ask? LSN will be running a 3 webinar series that cover how investors make their decisions, how to cover that information clearly in your pitch, and how to translate that into positive signal from investors. Register for these webinars below:
June 4 | 1:00 PM ET
De-Risking, Shaping, and Micro-Investment – Sign Up
Strong science alone is rarely enough to secure funding. Rick Berenson (Anchor Node project) explores how investors evaluate early-stage risk and how to transform a scientific story into a shaped, investable asset. Learn how micro-investment acts as an early filtering mechanism, how to sequence de-risking activities, and how to rigorously prepare for investor outreach ahead of RESI San Diego.
June 11 | 1:00 PM ET
From Pitch Deck to De-Risk Deck – Sign Up
Investors look for legibility and risk reduction, not just vision. Dennis Ford (Founder & CEO, Life Science Nation) explains why traditional pitch decks fail and introduces the “de-risk deck”—a framework centered on structured evidence and strategic capital formation. Gain critical insights into investor targeting, outreach strategy, and the realities of life science fundraising timelines before RESI San Diego.
June 18 | 1:00 PM ET
Science to Signal – Sign Up
Max Braht and Karen Deyo introduce the *Science to Signal* framework, designed to help startups translate scientific merit into clear investment signals. Learn how this system aligns development strategy with risk assessment, its enterprise implementation in incubators, and join Dennis Ford (CEO, Life Science Nation) for a closing Q&A on fundraising strategy ahead of RESI San Diego.
| Register for RESI San Diego |
Next Phase Newsletter 
Leave a comment